EUVIMEDEUVIMED entdecken
Open Access

Contrast-enhanced endoscopic ultrasound-guided additional ethanol ablation after early detection of occult residual pancreatic insulinoma

Ryo Sugiura iD, Masaki Kuwatani iD, Kazumichi Kawakubo, Shoya Shiratori, Soichiro Oda, Katsuma Nakajima, Naoya Sakamoto

Endoscopy · 01.03.2026 · 58 (S 01 S 01) · E370-E371

DOI: 10.1055/a-2817-2984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.03.2026. Verfasst von Ryo Sugiura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.

ORCID-Profile: Ryo Sugiura, Masaki Kuwatani

Zitieren

APA

Sugiura, R., Kuwatani, M., Kawakubo, K., Shiratori, S., Oda, S., Nakajima, K., & Sakamoto, N. (2026). Contrast-enhanced endoscopic ultrasound-guided additional ethanol ablation after early detection of occult residual pancreatic insulinoma. Endoscopy, 58(S 01 S 01), E370-E371. https://doi.org/10.1055/a-2817-2984

Vancouver

Sugiura R, Kuwatani M, Kawakubo K, Shiratori S, Oda S, Nakajima K, et al. Contrast-enhanced endoscopic ultrasound-guided additional ethanol ablation after early detection of occult residual pancreatic insulinoma. Endoscopy. 2026;58(S 01 S 01):E370-E371. doi:10.1055/a-2817-2984

BibTeX
@article{Sugiura2026,
  author = {Sugiura, Ryo and Kuwatani, Masaki and Kawakubo, Kazumichi and Shiratori, Shoya and Oda, Soichiro and Nakajima, Katsuma and Sakamoto, Naoya},
  title = {Contrast-enhanced endoscopic ultrasound-guided additional ethanol ablation after early detection of occult residual pancreatic insulinoma},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 01 S 01},
  pages = {E370--E371},
  doi = {10.1055/a-2817-2984}
}
Kostenlos starten →